Tom Vanden Berghe

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Cell death and differentiation

Biochemical Society transactions

Cells

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Magali Walravens, Ine Koeken, Tom Vanden Berghe
Therapeutic exploitation of ferroptosis. Biochemical Society transactions (2024)
Magali Walravens, Ine Koeken, Tom Vanden Berghe
Therapeutic exploitation of ferroptosis. Biochemical Society transactions 52 (2) (2024)
Cédric Peleman, Stig Hellemans, Geraldine Veeckmans, Wout Arras, Hao Zheng, Ine Koeken, Emily Van San, Behrouz Hassannia, Magali Walravens, Edissa Kayirangwa, Nateneal Tamerat Beyene, Mikhaïl Alfons Van Herck, Winnok Harald De Vos, Isabel Pintelon, Luc van Nassauw, Baptiste Oosterlinck, Annemieke Smet, Lieve Vits, Eveline Dirinck, An Verrijken, Joris De Man, Annelies van Eyck, Wilhelmus Josephus Kwanten, Luisa Vonghia, Ann Driessen, Koen Augustyns, Shinya Toyokuni, Benedicte Y De Winter, Christophe Van Steenkiste, Sven Francque, Tom Vanden Berghe
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease. Cell death and differentiation 31 (9) (2024)
Cédric Peleman, Stig Hellemans, Geraldine Veeckmans, Wout Arras, Hao Zheng, Ine Koeken, Emily Van San, Behrouz Hassannia, Magali Walravens, Edissa Kayirangwa, Nateneal Tamerat Beyene, Mikhaïl Alfons Van Herck, Winnok Harald De Vos, Isabel Pintelon, Luc van Nassauw, Baptiste Oosterlinck, Annemieke Smet, Lieve Vits, Eveline Dirinck, An Verrijken, Joris De Man, Annelies van Eyck, Wilhelmus Josephus Kwanten, Luisa Vonghia, Ann Driessen, Koen Augustyns, Shinya Toyokuni, Benedicte Y De Winter, Christophe Van Steenkiste, Sven Francque, Tom Vanden Berghe
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease. Cell death and differentiation (2024)
Magali Walravens, Ine Koeken, Tom Vanden Berghe
Therapeutic exploitation of ferroptosis. Biochemical Society transactions 52 (2) (2024)
Roberto Fernández-Acosta, Behrouz Hassannia, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L Pardo-Andreu
Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells. Cells 12 (5) (2023)
Geraldine Veeckmans, Emily Van San, Tom Vanden Berghe
A Guide to Ferroptosis, the biological rust of cellular membranes. The FEBS journal (2023)
Cédric Peleman, Samya Van Coillie, Symen Ligthart, Sze Men Choi, Jan De Waele, Pieter Depuydt, Dominique Benoit, Hannah Schaubroeck, Sven M Francque, Karolien Dams, Rita Jacobs, Dominique Robert, Ria Roelandt, Ruth Seurinck, Yvan Saeys, Mohan Rajapurkar, Philippe G Jorens, Eric A J Hoste, Tom Vanden Berghe
Ferroptosis and pyroptosis signatures in critical COVID-19 patients. Cell death and differentiation (2023)
Roberto Fernández-Acosta, Behrouz Hassannia, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L Pardo-Andreu
Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells. Cells 12 (5) (2023)
Roberto Fernández-Acosta, Behrouz Hassannia, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L Pardo-Andreu
Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells. Cells 12 (5) (2023)
Pauline Puylaert, Lynn Roth, Melissa Van Praet, Isabel Pintelon, Catalina Dumitrascu, Alexander L N van Nuijs, Greta Klejborowska, Pieter-Jan D F Guns, Tom Vanden Berghe, Koen Augustyns, Guido R Y De Meyer, Wim Martinet
Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques. Angiogenesis (2023)
Emily Van San, Angela C Debruyne, Geraldine Veeckmans, Yulia Y Tyurina, Vladimir A Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, Vivek Venkataramani, Shinya Toyokuni, Hülya Bayır, Peter Vandenabeele, Behrouz Hassannia, Tom Vanden Berghe
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell death and differentiation (2023)
Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Sze Men Choi, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts, Geert Dams, Wannes Weyts, Jelle Huysentruyt, Behrouz Hassannia, Irina Ingold, Suhas Lele, Evelyne Meyer, Maya Berg, Ruth Seurinck, Yvan Saeys, An Vermeulen, Alexander L N van Nuijs, Marcus Conrad, Andreas Linkermann, Mohan Rajapurkar, Peter Vandenabeele, Eric Hoste, Koen Augustyns, Tom Vanden Berghe
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nature communications 13 (1) (2022)
Bartosz Wiernicki, Hanne Dubois, Yulia Y Tyurina, Behrouz Hassannia, Hülya Bayir, Valerian E Kagan, Peter Vandenabeele, Andy Wullaert, Tom Vanden Berghe
Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell death & disease 11 (10) (2020)
Tom Vanden Berghe, Eric Hoste
Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids. Cell death and differentiation 26 (1) (2018)

Tom Vanden Berghe.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tom Vanden Berghe